![Characteristics of the inhibitory effects of atomoxetine and reboxetine... | Download Scientific Diagram Characteristics of the inhibitory effects of atomoxetine and reboxetine... | Download Scientific Diagram](https://www.researchgate.net/profile/Kazutaka-Ikeda-2/publication/43148358/figure/fig7/AS:647550126268418@1531399389714/Characteristics-of-the-inhibitory-effects-of-atomoxetine-and-reboxetine-on-GIRK-currents.png)
Characteristics of the inhibitory effects of atomoxetine and reboxetine... | Download Scientific Diagram
![Warning: Atomoxetine may increase suicidal feelings by activating the Kappa Opioid receptor : r/ADHD Warning: Atomoxetine may increase suicidal feelings by activating the Kappa Opioid receptor : r/ADHD](https://external-preview.redd.it/iVKTS19YavOujxVoQkGCwFq6hCNNzXP492aIBQUT5VU.jpg?auto=webp&s=10bcbab902c9e57f147421a226b34470bb0308c5)
Warning: Atomoxetine may increase suicidal feelings by activating the Kappa Opioid receptor : r/ADHD
![A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder | SpringerLink A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00213-013-2986-z/MediaObjects/213_2013_2986_Fig1_HTML.gif)
A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder | SpringerLink
![Methylphenidate and Atomoxetine Inhibit Social Play Behavior through Prefrontal and Subcortical Limbic Mechanisms in Rats | Journal of Neuroscience Methylphenidate and Atomoxetine Inhibit Social Play Behavior through Prefrontal and Subcortical Limbic Mechanisms in Rats | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/35/1/161/F3.large.jpg)
Methylphenidate and Atomoxetine Inhibit Social Play Behavior through Prefrontal and Subcortical Limbic Mechanisms in Rats | Journal of Neuroscience
![Enadoline and Butorphanol: Evaluation of κ-Agonists on Cocaine Pharmacodynamics and Cocaine Self-Administration in Humans | Journal of Pharmacology and Experimental Therapeutics Enadoline and Butorphanol: Evaluation of κ-Agonists on Cocaine Pharmacodynamics and Cocaine Self-Administration in Humans | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/299/1/147/F3.large.jpg)
Enadoline and Butorphanol: Evaluation of κ-Agonists on Cocaine Pharmacodynamics and Cocaine Self-Administration in Humans | Journal of Pharmacology and Experimental Therapeutics
![Catecholamines, not acetylcholine, alter cortical and perceptual dynamics in line with increased excitation-inhibition ratio | bioRxiv Catecholamines, not acetylcholine, alter cortical and perceptual dynamics in line with increased excitation-inhibition ratio | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2017/08/07/170613/F10.large.jpg)
Catecholamines, not acetylcholine, alter cortical and perceptual dynamics in line with increased excitation-inhibition ratio | bioRxiv
![Catecholamines, not acetylcholine, alter cortical and perceptual dynamics in line with increased excitation-inhibition ratio | bioRxiv Catecholamines, not acetylcholine, alter cortical and perceptual dynamics in line with increased excitation-inhibition ratio | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2017/08/07/170613/F1.large.jpg)
Catecholamines, not acetylcholine, alter cortical and perceptual dynamics in line with increased excitation-inhibition ratio | bioRxiv
Catecholamines alter the intrinsic variability of cortical population activity and perception | PLOS Biology
![PDF) Clinically Significant Drug–Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder PDF) Clinically Significant Drug–Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder](https://www.researchgate.net/profile/Jose-De-Leon-8/publication/337584926/figure/tbl1/AS:835005236387840@1576092170075/Pharmacokinetic-interactions-implicating-atomoxetine-as-a-victim-or-perpetrator-drug_Q320.jpg)
PDF) Clinically Significant Drug–Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder
![Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X04006523-gr4.gif)
Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect
![Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X04006523-gr1.gif)
Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect - ScienceDirect
![Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression - ScienceDirect Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014299920300406-gr2.jpg)